- Home
- DSGN vs GSBC Comparison
DSGN vs GSBC Comparison
Compare DSGN & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSGN | GSBC |
|---|---|---|
| Founded | 2017 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 673.5M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DSGN | GSBC |
|---|---|---|
| Price | $10.50 | $63.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $15.00 | ★ $60.50 |
| AVG Volume (30 Days) | ★ 170.8K | 56.5K |
| Earning Date | 01-01-0001 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | ★ 26.05 | N/A |
| EPS | N/A | ★ 4.74 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.56 |
| P/E Ratio | ★ N/A | $13.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $47.57 |
| 52 Week High | $11.14 | $67.70 |
Technical Indicators
Market Signals| Indicator | DSGN | GSBC |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 49.61 |
| Support Level | $9.62 | $59.60 |
| Resistance Level | $11.14 | $63.44 |
| Average True Range (ATR) | 0.50 | 1.68 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 47.57 | 51.44 |
Price Performance
Historical ComparisonAbout DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.